Myriad Genetics Inc (MYGN) financials · rev $824.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Myriad Genetics Inc (MYGN) rev $824.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $824.5M | $837.6M |
| Cost of Revenue | $247.9M | $252.2M |
| Gross Profit | $576.6M | $585.4M |
| Operating Income | -$387.2M | -$123.5M |
| Net Income | -$365.9M | -$127.3M |
| EPS (Diluted) | -$3.95 | -$1.41 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $706.6M | $1.03B |
| Current Assets | $332.6M | $298.0M |
| Cash & Equivalents | $149.6M | $102.4M |
| Inventory | $30.6M | $27.5M |
| PP&E | $114.0M | $117.4M |
| Total Liabilities | $338.6M | $326.5M |
| Current Liabilities | $133.8M | $164.1M |
| Short-term Debt | N/A | N/A |
| Long-term Debt | $119.9M | $39.6M |
| Total Debt | $119.9M† | $39.6M† |
| Shareholders' Equity | $368.0M | $701.1M |
| Retained Earnings | -$1.12B | -$756.8M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $1.80M | -$8.70M |
| Investing Cash Flow | -$27.4M | -$11.9M |
| Financing Cash Flow | $64.2M | -$7.40M |
| Net Change in Cash | $39.4M | -$29.0M |
FAQ
What is MYGN P/E and revenue?
Myriad Genetics Inc (MYGN) rev $824.5M.
What is MYGN revenue?
Myriad Genetics Inc last cached revenue is $824.5M (FY2025).
Is MYGN profitable?
Myriad Genetics Inc last cached net income is -$365.9M (FY2025).
What are MYGN total assets?
Myriad Genetics Inc last cached total assets are $706.6M (FY2025).
What is MYGN free cash flow?
No cached cash-flow row for MYGN yet.
Not investment advice. Cached statements, not a live tape.